Aluminum Corporation of China Limited (FRA:AOC)
Germany · Delayed Price · Currency is EUR | Market Cap | 19.63B +25.0% |
| Revenue (ttm) | 32.23B +3.0% |
| Net Income | 2.25B +40.4% |
| EPS | 0.13 +40.5% |
| Shares Out | n/a |
| PE Ratio | 8.72 |
| Forward PE | 5.22 |
| Dividend | 0.05 (6.02%) |
| Ex-Dividend Date | Sep 9, 2026 |
| Volume | n/a |
| Open | 0.8940 |
| Previous Close | 0.8800 |
| Day's Range | 0.8940 - 0.8940 |
| 52-Week Range | 0.7800 - 1.6260 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 27, 2026 |
About FRA:AOC
Aluminum Corporation of China Limited, together with its subsidiaries, primarily engages in the exploration and mining of bauxite, coal, and other resources in the People's Republic of China and internationally. It operates through five segments: Alumina, Primary Aluminum, Energy, Marketing, and Corporate and Other Operating. The Alumina segment mines for and purchases bauxite and other raw materials; refines bauxite into alumina; and sells alumina, as well as produces and sells refined alumina, gallium, and multi-form alumina bauxite. Its Prim... [Read more]
Financial Performance
In 2025, FRA:AOC's revenue was 241.13 billion, an increase of 1.69% compared to the previous year's 237.11 billion. Earnings were 12.65 billion, an increase of 2.68%.
Financial numbers in CNY Financial StatementsNews
Accendra Health Names Kenneth Gardner-Smith as President and Chief Executive Officer to Lead the Company's Next Chapter of Growth
RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) today named Kenneth Gardner-Smith as the Company's next President and Chief Executive Officer. Gardner-Smith, who has ...
Aluminum Corp of China Ltd's Dividend Analysis
Aluminum Corp of China Ltd's Dividend Analysis
Aluminum Corporation of China Earnings release: Q2 2026
Aluminum Corporation of China released its Q2 2026 earnings on August 27, 2026, summarizing the period's financial results.
Aluminum Corporation of China Quarterly report: Q2 2026
Aluminum Corporation of China has published its Q2 2026 quarterly earnings report on August 27, 2026.
Accendra Health Updates on Capital Allocation and CEO Succession Timing Plans
RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health (the “Company”) is providing an update on its capital allocation plans and the timeline for the replacement of its chief executive officer. Given recent...
ACH Maintains by UBS -- Price Target Lowered to $1.50
ACH Maintains by UBS -- Price Target Lowered to $1.50
Accendra Health Reports 111.1% Wider Q2 2026 Loss at -$0.19/Share
Significant Miss. Accendra Health, Inc. (NYSE:ACH) reported a disappointing Q2 2026 with a non-GAAP loss of $0.19 per share, missing analyst expectations by... The post Accendra Health Reports 111.1% ...
ACH Looks 49.4% Undervalued on GF Value™ Amid Revenue and EBITDA Forecast Revision
ACH Looks 49.4% Undervalued on GF Value™ Amid Revenue and EBITDA Forecast Revision
Accendra Health Announces Adoption of Tax Asset Preservation Plan To Protect Long Term Shareholder Value
RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the Company) announced today that its Board of Directors adopted a Section 382 Rights Agreement (the “Tax Asset Preservation Plan”) d...
Accendra Health Reports Second Quarter 2026 Financial Results
RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the Company) today reported financial results for the second quarter ended June 30, 2026. Unless otherwise noted, the results herein ...
Accendra Health's Ed Pesicka Announces Intent to Retire; Board of Directors Has Begun Successor Search
RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the Company) today announced that President and Chief Executive Officer Edward A. Pesicka has informed the Board of Directors of his ...
Accendra Health Announces Second Quarter 2026 Earnings Release Date and Conference Call
RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) plans to release financial results for the second quarter of 2026 on Monday, August 10, 2026, before trading begins on...
Accendra Health Announces Expiration and Final Results of Offers and Consent Solicitations
RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) today announced the expiration and final results of the previously announced offers to exchange (the “Exchange Offers”...
Aluminum Corp. of China downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Trina Chen downgraded Aluminum Corp. of China (ALMMF) to Sell from Neutral with a price target of HK$7.50, down from HK$12.50. The firm’s expects accelerating aluminum supply…
Accendra Health Announces Early Results of Offers and Consent Solicitations
RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) today announced the early results of the previously announced offers to exchange (the “Exchange Offers”) any and all o...
Accendra Health Announces Offers and Consent Solicitations
RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) today announced that it has commenced an offer to exchange (the “Exchange Offers”) any and all of the Company's outsta...
Accendra Health Reports First Quarter 2026 Financial Results and Announces Comprehensive Balance Sheet Optimization Transaction
RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) today reported financial results for the first quarter ended March 31, 2026, and announced a more than $1.5 billion comprehensive bala...
Accendra Health Announces First Quarter 2026 Earnings Release Date and Conference Call
RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) plans to release financial results for the first quarter of 2026 on Monday, May 11, 2026, before trading begins on the...
Aluminum Corporation of China Earnings release: Q1 2026
Aluminum Corporation of China released its Q1 2026 earnings on April 23, 2026, summarizing the period's financial results.
Aluminum Corp. of China upgraded to Neutral from Sell at Goldman Sachs
Goldman Sachs analyst Trina Chen upgraded Aluminum Corp. of China (ALMMF) to Neutral from Sell with a price target of HK$12.50, up from HK$9. The firm cites “strong” aluminum margins…
Aluminum Corporation of China Earnings release: Q4 2025
Aluminum Corporation of China released its Q4 2025 earnings on March 27, 2026, summarizing the period's financial results.
Aluminum Corporation of China Annual report: Q4 2025
Aluminum Corporation of China has published its Q4 2025 annual report on March 27, 2026.
Accendra Health Reports Fourth Quarter 2025 Financial Results
RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) today reported financial results for the fourth quarter ended December 31, 2025. Unless otherwise noted, the results herein reflect th...
Accendra Health Announces Fourth Quarter 2025 Earnings Release Date and Conference Call
RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) plans to release financial results for the fourth quarter of 2025 on Thursday, February 19, 2026, after trading ends o...
Aluminum Corp. of China downgraded to Sell from Buy at Goldman Sachs
Goldman Sachs downgraded Aluminum Corp. of China (ALMMF) to Sell from Buy with a price target of HK$9, up from HK$7.60. The firm adjusted ratings in the China basic metals…